- Board member since: 2026
- Independent in relation to the Company and its management: Yes
- Independent in relation to major shareholders: Yes
- Holdings in Alligator: None
- Other current positions: Chairman of the Board in Arendi AB and Lett Renovering AB. Board member of Medivir Aktiebolag, MedCap AB (publ), Attgeno AB, Akiram Therapeutics AB and Jonas & Kollegor AB. CEO and Board member of At Statistics AB.
Anna Törner – born in 1963 has extensive experience from the pharmaceutical industry, academic research, and regulatory authorities, with deep expertise in regulatory strategy and phase 2/3 study design. She is the founder and former CEO of SDS Life Science, previously a leading drug development consultancy in the Nordics.
Anna Törner has an MSc Pharmacy and an MSc Mathematical Statistics and PhD Medical Science (statistics) from Karolinska Institutet.